Clinical Trial Update: Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assesses the efficacy and safety of low-dose oral isotretinoin for seborrhea and seborrheic dermatitis, including quality of lif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrhea
• Seborrheic Dermatitis

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Seborrhea, Seborrheic Dermatitis | Phase 4 | Status: UNKNOWN